These topics were tagged with "Tuberculosis & Malaria"
-
29/10/2012 - Multi-drug resistant TB rises in Eastern Europe
TB, which cannot be cured with conventional drugs, is spreading in Eastern Europe. So far, strategies to fight the disease have shown little success because it is closely linked to poverty and exclusi... -
27/10/2012 - Structure discovered for promising tuberculosis drug target
Researchers have figured out the three-dimensional shape of the protein responsible for creating unique bonds within the cell wall of the bacteria that cause tuberculosis. Researchers at Johns Hopkins... -
27/10/2012 - Presenting the European Forum for TB Innovation: innovative thinking in progressing towards TB elimination in Europe
On March 9, 2012 the European Respiratory Society launched its first ever think tank on tuberculosis: the European Forum for TB Innovation. ... -
26/10/2012 - New opportunity for rapid treatment of malaria
Researchers have identified a new means to eradicate malaria infections by rapidly killing the blood-borne Plasmodium parasites that cause the disease. Malaria causes up to 3 million deaths each year,... -
26/10/2012 - Concern raised about finance scheme for malaria drugs
The charity Oxfam has cast doubt on an international scheme that aims to boost the provision of the most effective treatment for malaria. The UK government has contributed £70m to the Affordable Med... -
24/10/2012 - WHO report on tuberculosis highlights need for EU action
The highest proportions of TB patients with MDR-TB are in eastern Europe and central Asia. In several countries throughout the region 9-32 percent of new cases have MDR-TB and more than 50 percent of ... -
24/10/2012 - Blueprint: Plan for HIV must specify TB response
Every country seeking to prevent deaths from TB among people living with HIV needs to drive integration of its HIV and TB programs. Dr. Lucica Ditiu, executive secretary of the Stop TB Partnership, be... -
23/10/2012 - Risk of recurrence of active TB is high for people with HIV
The risk of developing active TB is three times higher for individuals with previous active TB compared to people with no history of active disease. People living with HIV who have a history of activ... -
19/10/2012 - Tuberculosis—from ancient plague to modern-day nemesis
The approach to tuberculosis control is not returning the kind of impact the world should expect to see. This week sees the launch of the WHO Global Tuberculosis Report 2012. This annual report provi... -
18/10/2012 - TB Alliance and FIND announce collaboration to promote development of TB drugs and diagnostics
As MDR-TB continues to spread, new efforts to coordinate TB detection and treatment hold promise. NEW YORK, NY/GENEVA, SWITZERLAND – A new partnership announced today will increase efforts to coordi... -
18/10/2012 - New malaria drug requires just one dose and appears twice as effective as existing regimen
The researchers developed a new type of ACT that could stop malaria in a single dose. Scientists are reporting development of a new malaria drug that, in laboratory tests, has been twice as effective ... -
18/10/2012 - Capacity to diagnose M/XDR-TB strengthened across Europe
WHO/Europe has established the European Tuberculosis Laboratory Initiative (ELI) to increase laboratory capacity to diagnose multidrug- and extensively drug-resistant tuberculosis (M/XDR-TB) across WH... -
18/10/2012 - Drug may help in hard-to-treat TB
Among patients with extensively drug-resistant (XDR) tuberculosis, adding linezolid (Zyvox) to standard therapies appears to improve treatment response, but with a high rate of adverse events, a phase... -
17/10/2012 - WHO launches the Global tuberculosis report 2012
WHO warns global fight against TB now at a crossroads. 17 October 2012 | Washington DC - An estimated 20 million people are alive today as a direct result of tuberculosis (TB) care and control, accord... -
16/10/2012 - Green light for start clinical trials of innovative and promising tuberculosis vaccine
European scientists are one step closer to delivering a new, safe and more effective vaccine against tuberculosis. Brussels/Lausanne/Zaragoza/Lelystad, 16 October 2012 – European scientists are one ... -
13/10/2012 - Malaria diagnostics technology landscape
The report is part of a broader effort by UNITAID to identify opportunities to create new markets, catalyse markets for underutilized products, and address market inefficiencies towards increased acce... -
10/10/2012 - Aeras signs agreement with GSK to jointly advance TB vaccine
Phase IIb proof of concept trial planned for Kenya, India and South Africa. Rockville, MD, USA (October 10, 2012) – Aeras announces that it has signed an agreement with GlaxoSmithKline Vaccines, S.A... -
10/10/2012 - Curing TB in Europe is more about politics than science
TB kills seven people in Europe every hour and, worryingly, rates of MDR-TB in the region are the highest in the world. Despite being considered as a disease of the past, tuberculosis (TB) kills seve... -
05/10/2012 - WHO and PATH publish updated MDR-TB Planning Toolkit
The toolkit is designed to help countries develop or strengthen their national response to drug-resistant tuberculosis. 3 October 2012 - Seattle, USA - The World Health Organization (WHO) and PATH hav... -
05/10/2012 - Romania boosts efforts against drug-resistant tuberculosis
While TB is steadily and slowly declining in the WHO European Region, the highest numbers of cases in the European Union are found in Romania. Today (2 October), Romania launches a four-year national ... -
04/10/2012 - Chloroquine makes comeback to combat malaria
The previously efficacious drug chloroquine is once again beginning to work against malaria. Malaria-drug monitoring over the past 30 years has shown that malaria parasites develop resistance to medi... -
04/10/2012 - WHO prequalifies a new artemisinin-based combination treatment (ACT) for malaria
Artesunate-Mefloquine Fixed-Dose Combination (ASMQ FDC) to be rolled out throughout Asia. Cipla, one of the leading generic pharmaceutical companies, along with the non-profit research and development... -
03/10/2012 - Launch of the Good Participatory Practice Guidelines for TB Drug Trials
The Stakeholder and Community Engagement Workgroup of the Critical Path to TB Drug Regimens initiative launches guidelines that will facilitate the involvement of communities and participants in the c... -
03/10/2012 - The National Plan for Multidrug-Resistant Tuberculosis Prevention and Management in Romania has been approved
An adequate funding and an exemplary mobilisation from the main actors in the field are needed so that MDR-TB will no longer be a threat for the Romanian and European citizens. The Stop-TB Partnership... -
29/09/2012 - New drug cut MDR-TB deaths
Delamanid, an investigational drug to combat tuberculosis, improves outcomes and reduces mortality among patients with the multidrug resistant form of the disease. Delamanid, an investigational drug t... -
29/09/2012 - The 43rd Union World Conference on Lung Health will tackle issues from MDR-TB to tobacco control and raise the profile of lung disease
2 million patients require simultaneous treatment for both tuberculosis and HIV each year. ... -
29/09/2012 - Romania: TB advocate travels to Brussels to urge the EU to address drug resistant TB
Romania, an EU member state since 2007 and classified as ‘upper-middle income country’, has one of the worst multi-drug resistant TB treatment success rates in the entire world. There is a certain... -
27/09/2012 - New Otago collaboration brings oral TB vaccine for humans closer
Researchers in New Zealand are inching closer to the development of the first effective oral vaccine to protect against tuberculosis. Researchers in New Zealand are inching closer to the development o... -
24/09/2012 - Sanofi and TB Alliance announce collaboration to accelerate new treatments against tuberculosis
Goal is to select novel clinical development candidates to help stop the global pandemic. Read the press release here. ... -
24/09/2012 - In Romania, chance determines whether drug-resistant TB patients survive
Romania sees around 1,300 new cases of MDR-TB annually. Multi-Drug Resistant TB (MDR-TB) is a strain of TB which is resistant to the two most powerful known anti-TB drugs, requiring intensive and care...
News
You can also search the entire site for "Tuberculosis & Malaria" by clicking here